Kestra Private Wealth Services’s Rani Therapeutics RANI Stock Holding History

Kestra Private Wealth Services’s Portfolio RANI Stock Details RANI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$215K	Buy	282,340 +17,181	+6%	+$15.2K	﹤0.01%	1666
2026 Q1	$195K	Buy	265,159 +10,347	+4%	+$13.2K	﹤0.01%	1646
2025 Q4	$344K	Buy	254,812 +28,670	+13%	+$43.3K	﹤0.01%	1359
2025 Q3	$113K	Buy	226,142 +70,002	+45%	+$36.5K	﹤0.01%	1601
2025 Q2	$80.2K	Buy	156,140 +16,984	+12%	+$13.9K	﹤0.01%	1561
2025 Q1	$175K	Buy	139,156 +19,536	+16%	+$28.9K	﹤0.01%	1405
2024 Q4	$164K	Buy	+119,620	New	+$251K	﹤0.01%	1334

Other funds holding RANI

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

WDL

Well Done LLC Holland, Michigan $743M AUM 22.58% 1-Year Est. Return

MOTCO San Antonio, Texas $1.17B AUM 23.84% 1-Year Est. Return

TIA

Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

JSSH

J. Safra Sarasin Holding $6.97B AUM 32.91% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

CSP

Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return

Kestra Private Wealth Services's RANI Position: Q2 2026 in Review

Kestra Private Wealth Services increased its Rani Therapeutics (RANI) stake by 6.5% in Q2 2026, buying an estimated $15.2K and bringing the position to 282,340 shares worth $215K. The position accounts for ﹤0.01% of the portfolio, ranked #1666.

Kestra Private Wealth Services first reported a position in RANI in Q4 2024 and has held it in 7 quarters since. The position peaked at $344K in Q4 2025. 13 funds tracked by Wall St. Rank hold RANI as of Q2 2026.

Kestra Private Wealth Services held 282,340 shares of Rani Therapeutics worth $215K as of Q2 2026.
Kestra Private Wealth Services bought 17,181 Rani Therapeutics shares in Q2 2026, an estimated $15.2K.
Rani Therapeutics made up ﹤0.01% of Kestra Private Wealth Services's portfolio in Q2 2026, its #1666 holding.
Kestra Private Wealth Services first reported a position in Rani Therapeutics in Q4 2024 and has held it in 7 quarters since.
Kestra Private Wealth Services's Rani Therapeutics position peaked at $344K in Q4 2025.
13 funds tracked by Wall St. Rank held Rani Therapeutics as of Q2 2026.

Based on Kestra Private Wealth Services's 13F filing for Q2 2026, filed 28 Jul 2026.